The media is off to the races, blacklisting coconut oil again. Seems like every year there is another study contradicting the study before. First coconut oil was bad, then it was good, then it turned bad again. But is this really about coconut oil? Or is it just a scapegoat?
After reviewing the recently published report, Dietary Fats and Cardiovascular Disease: A Presidential Advisory from the American Heart Association published in Circulation, it seems clear to me that there may be an ulterior agenda underlying the information presented.
First, let’s start with who funded the study. Pharmaceutical companies Pfizer, Glaxo-Smith Kline, AstraZeneca, Amgen and many more are listed as providing research grants for the authors. It just so happens that these companies manufacture cholesterol-lowering medications, like statins and the new drug Repatha. Why would they want to know whether coconut oil is good or bad for patients? Or whether eating carbohydrates is better than eating saturated fat? Well, for one, they will be well-positioned to market their drugs to the people who keep changing their diet based on the latest “research.”